Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
BBP Stock Summary
Top 10 Correlated ETFs
BBP
In the News

5 Least-Hurt Biotech ETFs of the Last Week
Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.

Can Health Care Stocks Outperform Again In 2023?
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

2 Sector ETFs Hovering Around a 52-Week High
We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.

5 Best Areas of Q3 of 2022 & Their Top ETFs
These ETF areas won in the third quarter of 2022.

Biotech & Crypto -- Best ETF Areas of Last Week
Biotech and cryptocurrency -- two ETF areas outperformed last week.

Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal
Biotechnology sector-related exchange traded funds continued to rally Friday on reports that Pfizer Inc. (NYSE: PFE) is looking to acquire Global Blood Therapeutics (NasdaqGS: GBT). On Friday, the Virtus LifeSci Biotech Products ETF (BBP) rose 1.8%, the SPDR S&P Biotech ETF (XBI) increased 3.6%, and the ALPS Medical Breakthroughs ETF (SBIO) was up 3.9%.

Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics
Global Blood Therapeutics (NasdaqGS: GBT) shares climbed Thursday, lifting biotechnology sector-related exchange traded funds, on speculation of takeover bids for the small drug developer. On Thursday, the Virtus LifeSci Biotech Products ETF (BBP) rose 7.2%, the SPDR S&P Biotech ETF (XBI) increased 5.2%, and the ALPS Medical Breakthroughs ETF (SBIO) was up 5.1%.

5 ETFs Riding High on the Biotech Comeback
Biotech, the downtrodden segment of the market, has made a solid comeback on bargain hunting.

Biotech ETFs Are Making a Comeback
Biotechnology stocks and sector-related exchange traded funds have been gaining momentum as investors return to this downtrodden segment of the market. Over the past month, the Virtus LifeSci Biotech Clinical Trials ETF (BBC) gained 15.5%, the Virtus LifeSci Biotech Products ETF (BBP) rose 12.8%, the SPDR S&P Biotech ETF (XBI) increased 11.3% and the ALPS [.

Biotech ETFs That Outperformed Last Week
Biotech ETFs was the biggest gainer last week.